Skip to content

Psilocybin: all studies

Page 368 of 440: studies 3,671 to 3,680 of 4,392, newest first. Back to the psilocybin overview

Research

Psychotherapeutisches Setting und Integration bei psychedelikaassistierter Therapie

Nervenheilkunde April 1, 2024 Manuela Brand, Luca V. Faerber, Laura Kaertner et al. 1 citation

ZUSAMMENFASSUNG Gegenstand und Ziel Der vorliegende Artikel beschäftigt sich mit der Behandlung von psychischen Erkrankungen mit psychedelischen Substanzen aus einem psychotherapeutischen Blickwinkel. Dabei wird die Rolle der „Integration“ von psychedelischen Erfahrungen diskutiert. Es wird der Frage nachgegangen, wie die außergewöhnlichen Erfahrungen, die Menschen unter Psychedelikaeinfluss...

Hanscarl Leuner und die Grundlagen der Psycholytischen Therapie

Nervenheilkunde April 1, 2024 Torsten Passie 1 citation

ZUSAMMENFASSUNG Hanscarl Leuner (1919–1996) gilt aufgrund seines wissenschaftlichen und organisatorischen Engagements als die zentrale Figur der Psycholytischen Therapie in Europa. Die Psycholytische Therapie versucht mithilfe geringer Dosen von Halluzinogenen wie LSD oder Psilocybin Abwehrstrukturen zu lockern und dadurch einen erweiterten Zugang zu unbewussten Konflikten und Seeleninhalten zu...

Microdosing psychedelics in the treatment of ADHD and comorbid disorders

European Psychiatry April 1, 2024 K. P. Kuypers 3 citations

Abstract Microdosing psychedelics has garnered considerable attention within both nonprofessional circles and the scientific community in recent years. This method involves taking small, non-hallucinogenic doses of substances like LSD or psilocybin over weeks or months, purportedly to enhance specific behaviors, emotions, or address psychiatric conditions. Exploring these assertions is crucial...

Current situation regarding psychedelics and magic mushroom in Korea

European Psychiatry April 1, 2024 J. S. Seo

Introduction Recently, the pros and cons have been debating in Korea even before the approval of use of medical marijuana with very strict limitations. And the next controversial topic is psychedelics. In 1890, when mescaline was first isolated from peyote cactus, clinical researches began, but due to its harmful effects, it was thereafter legally prohibited in 1970 in USA. However, a...

Older Adults in Psychedelic-Assisted Therapy Trials: A Systematic Review

European Psychiatry April 1, 2024 N. Kabir, B. Anderson, Lisa Bouchet et al. 1 citation

Introduction Growing clinical interest in psychedelic-assisted therapies has led to a second wave of research involving psilocybin, LSD, MDMA and other substances. Data suggests that these compounds have the potential to treat mental health conditions that are especially prevalent in older adults such as depression, anxiety, existential distress and post-traumatic stress disorder. Objectives...

The potential of 5‐methoxy‐N,N‐dimethyltryptamine in the treatment of alcohol use disorder: A first look at therapeutic mechanisms of action

Addiction Biology April 1, 2024 Stephan Tap 12 citations

Abstract Alcohol use disorder (AUD) remains one of the most prevalent psychiatric disorders worldwide with high economic costs. Current treatment options show modest efficacy and relapse rates are high. Furthermore, there are increases in the treatment gap and few new medications have been approved in the past 20 years. Recently, psychedelic‐assisted therapy with psilocybin and lysergic acid...

From Outsider to Insider: A Look at the Subculture of Microdosing

Deviant Behavior March 31, 2024 Blake Beaton, Jurg Gerber 2 citations

The practice of microdosing classic psychedelic drugs (e.g. LSD [lysergic acid diethylamide] and psilocybin) has not only become more commonplace, but has also been shown to have potential in treating various psychological impairments. Much is still unknown about how people who microdose psychedelic drugs learn the processes and protocols for microdosing. To uncover how people learn the various...

Psychedelics: reconnecting the brain to heal the mind

The Biochemist March 25, 2024 David Nutt 3 citations

Natural psychedelics such as magic mushrooms have a long history of human use of at least 7000 years. Their use underwent a resurgence in the 1950/1960s following the synthesis of LSD as a psychedelic and its use as a medicine with powerful therapeutic benefits. But because non-medical use led to massive cultural changes especially in young people, all psychedelics were banned globally in the...

Linda’s Last Trip

Educational Media Reviews Online March 22, 2024 Andrew Koval

Distributed by The Video Project, 145 - 9th St., Suite 230, San Francisco, CA 94103; 800-475-2638Produced by Adam GoldhammerDirected by Adam Goldhammer2023, Streaming, 45 mins Linda’s Last Trip is a heartfelt meditation into 64-year-old patient Linda Patchett’s terminal cancer diagnosis and her corresponding treatment with psilocybin mushrooms. Patchett’s journey delves into friendship, family,...

Editorial: Building resilience through healing communities

Frontiers in Psychiatry March 19, 2024 Jaswant Guzder, Geoffrey Walcott 1 citation

Medical training often fails to address the importance of culturally adapted tools and approaches that appreciate the beliefs and realities of patients influencing wellbeing, resilience patterns and intervention. The papers in this collection speak to value of integrating social and culture in both individual and community mental health engagement Transformative learning theory (TLT) (Mezirow...